RAZVAN TORNEA: Open Payments
NPI 1497866164 · SOUTHAMPTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 20 payments from 4 companies in 2025. Trend: 2023 $176 · 2024 $106 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 16 | $224 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Bausch Health US, LLC | 1 | $22 |
| ABBVIE INC. | 1 | $18 |
Products named: Qelbree, CAPLYTA, APLENZIN, VRAYLAR.
Industry payments across PA — which companies pay providers there.
